Background and objectives Hypothyroidism is highly prevalent among ESRD patients, but its clinical signifi-cance and the benefits of thyroid hormone replacement in this context remain unclear. Design, setting, participants, &measurements This study examined the association between hypothyroidism and all-cause mortality among 2715 adult dialysis patients with baseline thyrotropin levels measured between April of 2005 and April of 2011. Mortality was ascertained from Social Security Death Master Index and local registration systems. The association between hypothyroidism (thyrotropin greater than assay upper limit normal) and mortality was estimated using Cox proportional hazards models. To reduce the risk of observing reverse-causal asso...
Introduction: Thyroid dysfunction is a prevalent endocrine disorder in patients with chronic kidney ...
PURPOSE: Thyroid dysfunction is common, particularly among older women. The safety of thyroid hormon...
♦ Aims: We investigated dialysis duration, dose of eryth-ropoietin (EPO), and clinical manifestation...
Background and objectives Hypothyroidism is highly prevalent among ESRD patients, but its clinical s...
Background and objectivesHypothyroidism is highly prevalent among ESRD patients, but its clinical si...
Context and objectiveCompared with the general population, hemodialysis patients have a substantiall...
. These authors contributed equally to this work. " Membership of the Clinical Research Center ...
OBJECTIVE:Given that patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) have a di...
♦ Aims: We investigated dialysis duration, dose of eryth-ropoietin (EPO), and clinical manifestation...
Introduction. The kidney affects the thyroid gland causing various derangements in its function when...
none11noBackground/Aim: Clinical and subclinical hypothyroidism is more common in patients with end-...
Context: There are limited studies describing mortality and morbidity in patients treated for hypert...
Context and objectiveEnd-stage renal disease patients have a higher risk of thyroid disease compared...
BackgroundAdvanced chronic kidney disease (CKD) patients, including those receiving dialysis, have a...
Background and objectives Elevated parathyroid hormone levels may be associated with adverse clinica...
Introduction: Thyroid dysfunction is a prevalent endocrine disorder in patients with chronic kidney ...
PURPOSE: Thyroid dysfunction is common, particularly among older women. The safety of thyroid hormon...
♦ Aims: We investigated dialysis duration, dose of eryth-ropoietin (EPO), and clinical manifestation...
Background and objectives Hypothyroidism is highly prevalent among ESRD patients, but its clinical s...
Background and objectivesHypothyroidism is highly prevalent among ESRD patients, but its clinical si...
Context and objectiveCompared with the general population, hemodialysis patients have a substantiall...
. These authors contributed equally to this work. " Membership of the Clinical Research Center ...
OBJECTIVE:Given that patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) have a di...
♦ Aims: We investigated dialysis duration, dose of eryth-ropoietin (EPO), and clinical manifestation...
Introduction. The kidney affects the thyroid gland causing various derangements in its function when...
none11noBackground/Aim: Clinical and subclinical hypothyroidism is more common in patients with end-...
Context: There are limited studies describing mortality and morbidity in patients treated for hypert...
Context and objectiveEnd-stage renal disease patients have a higher risk of thyroid disease compared...
BackgroundAdvanced chronic kidney disease (CKD) patients, including those receiving dialysis, have a...
Background and objectives Elevated parathyroid hormone levels may be associated with adverse clinica...
Introduction: Thyroid dysfunction is a prevalent endocrine disorder in patients with chronic kidney ...
PURPOSE: Thyroid dysfunction is common, particularly among older women. The safety of thyroid hormon...
♦ Aims: We investigated dialysis duration, dose of eryth-ropoietin (EPO), and clinical manifestation...